Demiroğlu Çağdaş, Solakhan Mehmet
Department of Gynecology and Obstetrics Clinic, Medikal Point Hospital, Gynecology and Obstetrics Clinic, Gaziantep, Turkey.
Hasan Kalyoncu University School of Health Vocational, Department of Urology, Medikal Point Hospital, Gaziantep, Turkey.
Obstet Med. 2025 Jun 24:1753495X251332667. doi: 10.1177/1753495X251332667.
Pregnancy causes physiological changes, including ureteral compression by the enlarged uterus, leading to hydronephrosis in 90% of cases, though only 3% are symptomatic. This study evaluates outcomes in pregnant women with hydronephrosis managed with or without ureteral stenting to define criteria for intervention.
A retrospective analysis of 92 symptomatic pregnant women with hydronephrosis diagnosed at MP Hospital (2019-2024) was conducted. Patients were categorized into conservative treatment (Group I) and stenting (Group II). Renal dilation, parenchymal thickness, and infection status were assessed.
Patients in Group II also had hydronephrosis at earlier gestational weeks ( < .001), and also had more male fetuses ( = .033), lower parenchymal thickness ( < .001), and higher infection rates ( < .001).
Indicators for stenting in pregnancy-related hydronephrosis include parenchymal thickness ≤20 mm, renal dilation >30 mm, early symptoms, and infections.
妊娠会引起生理变化，包括增大的子宫压迫输尿管，90%的病例会导致肾积水，不过只有3%有症状。本研究评估了采用或不采用输尿管支架置入术治疗的妊娠合并肾积水孕妇的结局，以确定干预标准。
对MP医院（2019 - 2024年）诊断为有症状的92例妊娠合并肾积水孕妇进行回顾性分析。患者分为保守治疗组（I组）和支架置入组（II组）。评估肾扩张、实质厚度和感染状况。
II组患者在妊娠早期孕周时也存在肾积水（P <.001），男性胎儿更多（P = 0.033），实质厚度更低（P <.001），感染率更高（P <.001）。
妊娠相关肾积水的支架置入指征包括实质厚度≤20 mm、肾扩张>30 mm、早期症状和感染。
